Job opportunity
Date: Oct 05, 2026
Location: Basel, Switzerland
Role Type: Onsite working, #LI-Onsite
What if your expertise in biochemistry and biophysics could help identify the anticancer medicines of the future? As a Scientific Associate in our Oncology Biochemistry group at Novartis, you will develop innovative assays, characterize protein targets, and explore how promising compounds function. Supporting both low molecular weight and radioligand therapy projects, you will engage in collaboration across disciplines and sites to generate high-quality scientific insights that advance oncology drug discovery.
At Novartis, we are committed to reimagining medicine together and rewarding the individuals who contribute to our mission.
Expected Annual Base Salary Range for this role: 65,870.00 - 122,330.00 CHF
The base salary offered is determined based on gender-neutral objectives, such as relevant skills, competencies, and experience in alignment with the Novartis pay setting policy. Upon joining Novartis, salaries are reviewed periodically.
In addition to your base salary, you may be eligible for a performance-based bonus based on certain performance parameters.
The rewards of being part of our team extend beyond base pay and incentives. We also provide a variety of competitive benefits designed to help you thrive personally and professionally, including:
Please note that benefits and compensation may vary by country and are subject to local legal requirements, including provisions of collective bargaining agreements where applicable.
Novartis is dedicated to building an outstanding, inclusive work environment and diverse teams that represent the patients and communities we serve.
Helping people with disease and their families takes more than innovative science. It requires a community of smart, passionate individuals like you working together to achieve breakthroughs that change patients' lives. Ready to create a brighter future together?
To apply, please use the form below. Only applications matching the job profile will be considered.